New Classifications of Five Distinct “Sleep” Profi... ...
A Professional Overview of Hypertension ...
High-speed imaging tracks live brain cell activity...
Drug candidate slows motor neuron disease progress...
Drug candidate slows motor neuron disease progress...
Mark Cuban: A Master Disrupter for American Health...
Superbugs on your plate: How antimicrobial resistance spread...
June 13,2026
Can marijuana cause lung cancer?...
June 12,2026
Standard depression screening could be missing key symptoms ...
June 11,2026
More women are having babies later in life. How to improve y...
June 10,2026
For severe babesiosis, red blood cell exchange is associated...
June 09,2026
Cause or effect? Study answers question about gene linked wi...
June 08,2026
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
Eye Infections (Updated) | Clinical Medicine...
Announcement of the 2025 Nobel Prize in ...
Dr. Fauci among hundreds who've contract...
Why are young, healthy adults experienci...
Reprogramming Stem Cells Could Cure Type...
More News
Statin use reduces mortality and stroke risk in dementia patients, new study shows

Statin use reduces mortality and stroke risk in dementia patients, new study shows

by The European Academy of NeurologyThe use of statins is significantly associated with a reduction in the risk of mortality in dementia patients, new research presented today at the 5th European Acad
Neurology March 07,2024
Statin use reduces mortality and stroke risk in dementia patients, new study shows

Statin use reduces mortality and stroke risk in dementia patients, new study shows

by The European Academy of NeurologyThe use of statins is significantly associated with a reduction in the risk of mortality in dementia patients, new research presented today at the 5th European Acad
Neurology March 07,2024
Long-term use of opioid patches common among persons with Alzheimer's disease

Long-term use of opioid patches common among persons with Alzheimer's disease

by University of Eastern FinlandApproximately seven per cent of persons with Alzheimer's disease use strong pain medicines, opioids, for non-cancer pain for a period longer than six months, a
Neurology March 07,2024
Long-term use of opioid patches common among persons with Alzheimer's disease

Long-term use of opioid patches common among persons with Alzheimer's disease

by University of Eastern FinlandApproximately seven per cent of persons with Alzheimer's disease use strong pain medicines, opioids, for non-cancer pain for a period longer than six months, a
Neurology March 07,2024
Can older adults with dementia continue to drive? More study is needed

Can older adults with dementia continue to drive? More study is needed

by American Geriatrics SocietyHow do you know when it's time for an older adult with mild dementia to stop driving? Dementia is a general term for a decline in mental ability severe enough to inte
Neurology March 07,2024
Can older adults with dementia continue to drive? More study is needed

Can older adults with dementia continue to drive? More study is needed

by American Geriatrics SocietyHow do you know when it's time for an older adult with mild dementia to stop driving? Dementia is a general term for a decline in mental ability severe enough to inte
Neurology March 07,2024
Machine learning can predict rate of memory change

Machine learning can predict rate of memory change

by Alzheimer's Research UKIn new research published today, researchers have created a machine learning algorithm that is able to form two distinct groups of people who have early memory probl
Neurology March 07,2024
Machine learning can predict rate of memory change

Machine learning can predict rate of memory change

by Alzheimer's Research UKIn new research published today, researchers have created a machine learning algorithm that is able to form two distinct groups of people who have early memory probl
Neurology March 07,2024
Brain exercise and training program to improve mind and body wellness in individuals with mild cognitive impairment

Brain exercise and training program to improve mind and body wellness in individuals with mild cognitive impairment

by Courtney Caprara,University of PittsburghIndividuals with mild cognitive impairment have a new resource in Pittsburgh with the recently establishedBrain Training and Exercise(BRiT
Neurology March 07,2024
Brain exercise and training program to improve mind and body wellness in individuals with mild cognitive impairment

Brain exercise and training program to improve mind and body wellness in individuals with mild cognitive impairment

by Courtney Caprara,University of PittsburghIndividuals with mild cognitive impairment have a new resource in Pittsburgh with the recently establishedBrain Training and Exercise(BRiT
Neurology March 07,2024
Meditation and music may help reverse early memory loss in adults at risk for Alzheimer's disease

Meditation and music may help reverse early memory loss in adults at risk for Alzheimer's disease

by IOS PressIn a recent study of adults with early memory loss, a West Virginia University research team lead by Dr. Kim Innes found that practice of a simple meditation or music listening progra
Neurology March 07,2024
Meditation and music may help reverse early memory loss in adults at risk for Alzheimer's disease

Meditation and music may help reverse early memory loss in adults at risk for Alzheimer's disease

by IOS PressIn a recent study of adults with early memory loss, a West Virginia University research team lead by Dr. Kim Innes found that practice of a simple meditation or music listening progra
Neurology March 07,2024
Experimental drug shows promise in treating Alzheimer's disease

Experimental drug shows promise in treating Alzheimer's disease

by American Society of AnesthesiologistsAn experimental drug shows promise in treating Alzheimer's disease by preventing inflammation and removing abnormal protein clumps in the brain that are ass
Neurology March 07,2024
Experimental drug shows promise in treating Alzheimer's disease

Experimental drug shows promise in treating Alzheimer's disease

by American Society of AnesthesiologistsAn experimental drug shows promise in treating Alzheimer's disease by preventing inflammation and removing abnormal protein clumps in the brain that are ass
Neurology March 07,2024
Researchers identify genetic factors that contribute to Alzheimer's disease

Researchers identify genetic factors that contribute to Alzheimer's disease

by Boston University School of MedicineResearchers have identified several new genes responsible for Alzheimer's disease (AD) including those leading to functional and structural changes in t
Neurology March 07,2024
Researchers identify genetic factors that contribute to Alzheimer's disease

Researchers identify genetic factors that contribute to Alzheimer's disease

by Boston University School of MedicineResearchers have identified several new genes responsible for Alzheimer's disease (AD) including those leading to functional and structural changes in t
Neurology March 07,2024
Possible pathway to new therapy for Alzheimer's disease

Possible pathway to new therapy for Alzheimer's disease

by Boston University School of MedicineResearchers have uncovered an enzyme and a biochemical pathway they believe may lead to the identification of drugs that could inhibit the production of bet
Neurology March 07,2024
Possible pathway to new therapy for Alzheimer's disease

Possible pathway to new therapy for Alzheimer's disease

by Boston University School of MedicineResearchers have uncovered an enzyme and a biochemical pathway they believe may lead to the identification of drugs that could inhibit the production of bet
Neurology March 07,2024
Taking proton pump inhibitors not linked to higher dementia risk

Taking proton pump inhibitors not linked to higher dementia risk

by American Geriatrics SocietyProton pump inhibitors (PPIs) are medicines commonly prescribed to treat acid-related digestive problems, including gastroesophageal reflux disease (or GERD). As of
Neurology March 07,2024
Taking proton pump inhibitors not linked to higher dementia risk

Taking proton pump inhibitors not linked to higher dementia risk

by American Geriatrics SocietyProton pump inhibitors (PPIs) are medicines commonly prescribed to treat acid-related digestive problems, including gastroesophageal reflux disease (or GERD). As of
Neurology March 07,2024
More News
Week’s Top
Podcasts
... Preparing for a tough exam? A tough gym workout could help with your studies ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... Brain activity goes to extremes in soccer fans, neuroimaging reveals ...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com